Portfolio Lab

BillionToOne, Inc.

  • Stock
  • Ticker BLLN
  • Nasdaq

Health care · Health care services · USA

$89.92 −0.31%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of BillionToOne, Inc. since 11/2025, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

BLLNGlobal equities (VT)

$10,000 grew to $8,254. Global equities (VT): $10,429.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −50.8% in 03/2026, measured from the peak in 11/2025. It took 8 months to get back to the old peak.

1-year return
−6.0%
Return p.a. since 11/2025
−16.9%
Volatility p.a.
74.9%
Largest decline
−50.8%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue4559678496108109123
Gross profit2638435869797787
Operating income-12-2.3-1.69.610185.511
EBITDA-9.9-0.50.11112207.313
Net income-11-4.0-0.25.76.0188.117
Earnings per share-1.13-0.39-0.020.100.110.340.150.32
Balance sheet
Total assets302––328633701730760
Liabilities134––148153195193194
Equity-252-253-250-240480506537567
Cash191192189195496537549562
Long-term debt51––5557909189
Cash flow
Operating cash flow-8.42.61.210.011159.113
Capital expenditure-2.1-2.3-2.9-2.1-1.5-4.5-4.0-3.9
Free cash flow-100.3-1.77.99.3115.18.6

Value it:DCF calculatorMultiples calculator

Annual returns

* partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026$0.32
5 Aug 2026$0.15
6 May 2026$0.34
11 Mar 2026$0.11
10 Dec 2025$0.10

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€4.4bn
Market cap in trading currency
$4.83bn
Enterprise value
$4.36bn
P/E
97.7
P/S
11.06
P/B
8.53
EV/Sales
9.98
EV/EBITDA
84.0
Earnings yield
1.0%
FCF yield
0.7%

Results (last four quarters)

Revenue
$437m
Gross profit
$312m
EBITDA
$51.9m
Net income
$49.4m
Earnings per share
$0.92
Revenue per share
$8.13
Revenue growth
+47.2%
Earnings growth
+204.5%

Profitability

Gross margin
71.4%
Operating margin
10.2%
Net margin
11.3%
Return on equity
8.7%
Return on assets
6.5%

Balance sheet and cash flow

Cash
$562m
Cash per share
$10.45
Financial debt
$89.0m
Debt/equity %
16
Current ratio
11.25
Book value per share
$10.54
Operating cash flow
$47.9m
Free cash flow
$33.9m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
53.7m
Volume
819,335
Avg. volume 3 months
609,144
Relative volume
1.3

Price and technicals

Price
$89.92
1 day
−0.3%
52-week high
$149.97
52-week low
$64.03
Distance to 52-week high
−40.0%
Distance to 52-week low
+40.4%
Distance to 50-day line
−15.5%
Distance to 200-day line
−8.1%
RSI (14)
30
Volatility 1M
48.7%

Performance

1 week
−14.5%
1 month
−14.9%
3 months
−7.0%
6 months
+4.7%
YTD
+9.9%
1 year
−7.7%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has BLLN performed since 11/2025?

$10,000 grew to $8,254 by 20 Nov 2026, which is −16.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BLLN?

Volatility was 74.9% per year, measured on monthly returns. The largest decline from a peak was −50.8%, with the low in 03/2026.

How does BLLN compare with a broad equity ETF?

Over the same period Global equities (VT) returned +4.1% per year at 16.4% volatility, BLLN returned −16.9% at 74.9%. The correlation of monthly returns was 0.05; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

BillionToOne, Inc. (BLLN): Return and risk | Portfolio Lab